{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:54:36Z","timestamp":1793073276165,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004406"],"award-info":[{"award-number":["UM1TR004406"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["75N94021D00020-0-759402100001-1"],"award-info":[{"award-number":["75N94021D00020-0-759402100001-1"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.gim.2026.102586","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:09:28Z","timestamp":1776787768000},"page":"102586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A North Carolina newborn screening pilot for mucopolysaccharidosis II: Evaluating endogenous nonreducing end glycosaminoglycan analysis and IDS sequencing as higher-tier testing options"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-6599","authenticated-orcid":false,"given":"Katerina S.","family":"Kucera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Clinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica R.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Migliore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Torrice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javan K.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia N.","family":"Apoian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstyn A.","family":"Tober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Gehtland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Shone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Jalazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine W.","family":"Rehder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Raspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Muenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gim.2026.102586_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40246-024-00701-w","article-title":"Molecular basis of mucopolysaccharidosis type II (Hunter syndrome): first review and classification of published IDS gene variants","volume":"18","author":"Zanetti","year":"2024","journal-title":"Hum Genomics"},{"key":"10.1016\/j.gim.2026.102586_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"issue":"3","key":"10.1016\/j.gim.2026.102586_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.gim.2026.102586_bib4","article-title":"The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome","volume":"22","author":"Eisengart","year":"2020","journal-title":"Mol Genet Metab Rep"},{"issue":"1-2","key":"10.1016\/j.gim.2026.102586_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108576","article-title":"Genotype-phenotype findings in patients with mucopolysaccharidosis II from the Hunter Outcome Survey","volume":"143","author":"Muenzer","year":"2024","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.gim.2026.102586_bib6","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural progression of neurological disease in mucopolysaccharidosis type II","volume":"127","author":"Holt","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.gim.2026.102586_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s13023-023-02805-3","article-title":"Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study","volume":"18","author":"Muenzer","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.gim.2026.102586_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2026.102586_bib9","series-title":"GeneReviews\u00ae","article-title":"Mucopolysaccharidosis type II","author":"Scarpa","year":"2025"},{"issue":"5","key":"10.1016\/j.gim.2026.102586_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40259-024-00675-0","article-title":"Targeting neurological aspects of mucopolysaccharidosis type II: enzyme replacement therapy and beyond","volume":"38","author":"Zanetti","year":"2024","journal-title":"BioDrugs"},{"issue":"7","key":"10.1016\/j.gim.2026.102586_bib11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/jpm12071023","article-title":"Newborn screening program for mucopolysaccharidosis type II and long-term follow-up of the screen-positive subjects in Taiwan","volume":"12","author":"Lin","year":"2022","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.gim.2026.102586_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/ijns10040071","article-title":"A systematic literature review on the global status of newborn screening for mucopolysaccharidosis II","volume":"10","author":"Ayodele","year":"2024","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.gim.2026.102586_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.10.012","article-title":"Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States","volume":"25","author":"Ream","year":"2023","journal-title":"Genet Med"},{"issue":"1-2","key":"10.1016\/j.gim.2026.102586_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107557","article-title":"Newborn screening for mucopolysaccharidosis type II: lessons learned","volume":"140","author":"Burton","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.gim.2026.102586_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/ijns6040079","article-title":"Validation and implementation of a highly sensitive and efficient newborn screening assay for mucopolysaccharidosis type II","volume":"6","author":"Bilyeu","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.gim.2026.102586_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1399-0004.2007.00843.x","article-title":"Identification of a novel pseudodeficiency allele in the GLB1 gene in a carrier of GM1 gangliosidosis","volume":"72","author":"Gort","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.gim.2026.102586_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpeds.2019.04.027","article-title":"The North Carolina experience with mucopolysaccharidosis type I newborn screening","volume":"211","author":"Taylor","year":"2019","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.gim.2026.102586_bib18","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1515\/cclm-2020-0064","article-title":"The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I","volume":"58","author":"Polo","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.gim.2026.102586_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107685","article-title":"Endogenous, non-reducing end glycosaminoglycan biomarkers for the mucopolysaccharidoses: accurate diagnosis and elimination of false positive newborn screening results","volume":"140","author":"Saville","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"1-2","key":"10.1016\/j.gim.2026.102586_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107632","article-title":"Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis","volume":"140","author":"Herbst","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.gim.2026.102586_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/01.PDR.0000141987.69757.DD","article-title":"Disease-specific markers for the mucopolysaccharidoses","volume":"56","author":"Fuller","year":"2004","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.gim.2026.102586_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2014.09.009","article-title":"A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses","volume":"114","author":"Zhang","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gim.2026.102586_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.701","article-title":"Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"3","author":"Zhang","year":"2023","journal-title":"Curr Protoc"},{"key":"10.1016\/j.gim.2026.102586_bib24","series-title":"Time Study for Measuring I2S Enzyme Activity Using a PerkinElmer QSight\u00ae225MD UHPLC","author":"Yeung","year":"2023"},{"issue":"5","key":"10.1016\/j.gim.2026.102586_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1399-0004.1998.tb02746.x","article-title":"Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients","volume":"53","author":"Froissart","year":"1998","journal-title":"Clin Genet"},{"issue":"10","key":"10.1016\/j.gim.2026.102586_bib27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/dmcn.13467","article-title":"Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype","volume":"59","author":"Vollebregt","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.gim.2026.102586_bib28","article-title":"The link between ten-eleven translocation-2 (Tet2) related clonal hematopoiesis and sequential onset of two hematologic malignancies","volume":"12","author":"Huang","year":"2025","journal-title":"Genes Dis"},{"issue":"5","key":"10.1016\/j.gim.2026.102586_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00431-019-03341-8","article-title":"Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study","volume":"178","author":"Zanetti","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.gim.2026.102586_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00691155","article-title":"Morphological observations in the nervous system of prenatal mucopolysaccharidosis II (M. Hunter)","volume":"48","author":"Meier","year":"1979","journal-title":"Acta Neuropathol"},{"issue":"1-2","key":"10.1016\/j.gim.2026.102586_bib31","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl Sci Rare Dis"},{"issue":"2","key":"10.1016\/j.gim.2026.102586_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108612","article-title":"High precision newborn screening for mucopolysaccharidosis type I by enzymatic activity followed by endogenous, non-reducing end glycosaminoglycan analysis","volume":"144","author":"Herbst","year":"2025","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gim.2026.102586_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns8010009","article-title":"Evaluation of two methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis type II","volume":"8","author":"Herbst","year":"2022","journal-title":"Int J Neonatal Screen"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360026009044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360026009044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:23:58Z","timestamp":1786663438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360026009044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1098360026009044"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2026.102586","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A North Carolina newborn screening pilot for mucopolysaccharidosis II: Evaluating endogenous nonreducing end glycosaminoglycan analysis and IDS sequencing as higher-tier testing options","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2026.102586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"102586"}}